Background: Rhinovirus (RV) can exacerbate allergen-driven asthma. However, it
exacerbations in children and nearly 50% in adults, with human rhinovirus (RV) being the most common virus identified. 1, 2 However, in addition to exacerbating preexisting asthma, it has been suggested that viral infection may predispose to development of asthma or induce symptoms similar to those seen in allergic asthmatics. Clinical studies have shown that children at an early age who wheeze because of RV infections are at significantly increased risk of developing asthma. 3, 4 Moreover, longitudinal analyses found that preschool children can have more than six RV infections per year and serial infections can lead to episodes of wheezing reminiscent of asthma. 5, 6 This has then led to the hypothesis that recurrent RV infection may not only be a stimulus for asthma progression but could also play a significant role in the development of asthmatic inflammatory features in the lung in childhood without an allergen trigger. 7 In line with this, a number of mouse studies have shown that RV infection can lead to rapid transient influx of inflammatory cells into the lungs, including neutrophils and T cells, which results in acute asthmalike symptoms. [8] [9] [10] [11] Airway remodeling is an important feature in severe asthma that manifests as subepithelial thickening, extracellular matrix deposition or fibrosis, and an increase in airway smooth muscle (ASM) mass. [12] [13] [14] Originally, it was thought that chronic airway inflammation precedes airway structural changes, as remodeling features were suggested to be absent in symptomatic infants with an airflow limitation. 15 However, it has been suggested more recently that components of an airway remodeling response can also be present in preschool children with airflow limitation even before any diagnosis of asthma. 16, 17 Thus, remodeling may also begin in early childhood due to extrinsic influences such as viral infections that could be unrelated to allergen exposure. 7 Substantiating this idea, several studies have shown that RV infection of cultured lung epithelial cells can upregulate several soluble inflammatory molecules linked to airway remodeling in asthma including amphiregulin, vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and matrix metalloproteinase 9
(MMP-9). [18] [19] [20] [21] In this context, previous work from our laboratory showed that another inflammatory molecule, tumor necrosis factor (TNF) superfamily member 14 (TNFSF14), also termed LIGHT or CD258, is a strong driver of airway remodeling in models of allergeninduced severe asthma. 22 Moreover, we recently also showed that LIGHT can contribute to fibrosis in the lungs and skin in models of scleroderma. 23, 24 This led us to question whether RV might also upregulate the expression of LIGHT and then whether recurrent RV infection could promote airway remodeling that involved this cytokine regardless of allergen exposure. Indeed, here we
show that infection of na€ ıve mice with RV1B alone promotes expression of LIGHT in the lungs, and that LIGHT, together with TGF-b and IL-1b, is active in promoting airway fibrosis and increases in smooth muscle mass when mice are infected multiple times with RV1B. The data suggest that even without allergen sensitization RV can drive production of inflammatory factors that can contribute to airway remodeling and that RV may enhance asthma-related remodeling through upregulating common factors that are also active with allergen. 
| RV generation and experimental protocols
RV1B stocks were generated as described elsewhere. 25 Mice were infected recurrently with 50 ll of RV1B (~5 9 10 7 PFU/mL) intrana- Trichrome blue or anti-alpha-smooth muscle actin (Sigma) and scored with an image analysis system (Image-Pro Plus, Media Cybernetics, Rockville, Md). 22, 23 In some experiments, smooth muscle thickness was also evaluated using immunofluorescence staining as described elsewhere. 23 Results using gene-deficient mice or blocking reagents are expressed as induced responses above background levels in na€ ıve unmanipulated mice. dose given via the lungs to mice, viral load is maximal at 1-day postinfection, and RV1B is not detectable thereafter. 29 Thus, mice were exposed i.n. to RV1B twice a week for a period of 3 weeks to allow increased infection in the lower airways and attempt to create a model that potentially mimics inflammatory activity associated with multiple exposures in children ( Figure 1 ).
| Lung cell isolation
Significantly, we observed that multiple infections with RV1B led to collagen deposition in the subepithelial regions ( Figure 1A ), and To further confirm these results, we treated WT mice with a lymphotoxin beta receptor fusion protein (LTbR.Fc) that can block the interaction between LIGHT and its two receptors LTbR and HVEM. 22 Similar to LIGHTÀ/À mice, WT mice treated with LTbR.Fc had less fibrosis ( Figure 3C ) and smooth muscle mass ( Figure 3D ).
LTbRÀ/À mice lack lymph nodes and display other developmental issues, and thus cannot be used to effectively assess the Figure 4A ,B) over that seen with HDM. We previously reported that LIGHT contributed to remodeling in the lungs of HDM-challenged mice, but eosinophil numbers, the overall extent of peribronchial cellular infiltrates, and the overall Th2 response were largely unaltered, 22 and this observation was reproduced here. Moreover, LIGHT still contributed to remodeling driven by HDM given together with RV1B
( Figure 4A,B) , although a substantial level of remodeling was evident in the absence of LIGHT.
| IL-1b and TGF-b also participate in airway remodeling induced by recurrent rhinovirus exposure
As remodeling was not completely negated by neutralizing the activity of LIGHT, we then sought other molecules that might be upregulated by RV and could contribute to the remodeling process. IL-1b is one candidate as revealed by induction of lung remodeling in mice where this cytokine was overexpressed in the lungs using a transgenic 30 or adenoviral approach. 31 RV1B has been shown to induce IL-1b in the lungs in vivo, 8 and we confirmed an early increase in mRNA for IL-1b in lung tissue of RV1B-infected mice. Expression of IL-1b mRNA was primarily in sorted Ly6G+ neutrophils and to a lesser extent Ly6GÀ cells from na€ ıve mouse lungs, and this was upregulated after RV1B infection ( Figure S3A,B) . Further suggesting that neutrophils were a primary source of this cytokine, depletion of these cells with anti-Ly6G antibody significantly reduced RV1B-induced IL-1b expression ( Figure S3C ). We did not see a strong signal for IL-1b in lung CD45À cells, again with the caveats discussed above, but observed significant upregulation of IL-1b mRNA after infection of human bronchial epithelial cells (BEAS-2B), but not in A549 alveolar epithelial cells ( Figure S3D , and data not shown). This is consistent with a previous study of IL-1b expression in isolated bronchial epithelial cells infected with RV. 20 We then treated mice with a neutralizing antibody to IL-1 given 24 hours before each recurrent RV1B challenge. Similar to inhibiting LIGHT activity, blocking IL-1b significantly reduced fibrosis (Figure 5A ) as well as smooth muscle mass ( Figure 5B ). This was also accompanied by a significant decrease in BAL neutrophils but comparable lymphocytes numbers, reminiscent of the effect when LIGHT was neutralized ( Figure S4A ,B). Viral load was again comparable in both groups ( Figure S4C ).
Lastly, we assessed any contribution of TGF-b, a cytokine thought to be central to lung remodeling driven by many stimuli. TGF-b activation has been suggested to be modulated in part by IL-1b, 31 and we previously found that TGF-b expression could be upregulated in lung macrophages by LIGHT, 22 although many other factors are likely to determine its production. We did not find a significant change in total lung TGF-b1 levels in mice acutely exposed to RV1B, but we did observe increased TGF-b1 mRNA expression from sorted Ly6G+ neutrophils after infection ( Figure S5A ). We then treated mice with a TGF-b1 neutralizing antibody. TGF-b has been primarily associated with collagen production. However, a significant decrease in a-SMA expression was seen in the treated group whereas collagen accumulation in the subepithelial region was comparable with the control group ( Figure 6A 
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One publication also reported RV could induce collagen V expression in bronchial epithelial cells, although whether this was a direct activity was not clear. 34 The latter study additionally observed in mice that a single dose of RV1B could enhance fibronectin and collagen I gene expression within 2 days of infection. 34 Our data further add to these findings and suggest that RV is capable of inducing lung remodeling without allergen exposure. Moreover, we found that an appreciable increase in airway remodeling was observed in the lungs only with repeated rhinovirus infection, implying that the clinical studies related to wheezing in children following recurrent infections may indeed be partially related to airway remodeling.
Which molecules promote airway remodeling downstream of allergen or in this case RV is still being elucidated. Our data highlight three molecules, LIGHT, IL-1b, and TGF-b, as important for the RVinduced response, although others may also be active. We previously showed that LIGHT is a strong mediator of airway remodeling induced by repetitive intranasal exposure of mice to HDM allergen, 22 and we demonstrate here that LIGHT is also upregulated and active during RV infection. Furthermore, LIGHT still significantly contributed to airway remodeling features in mice concomitantly challenged with RV and allergen. As suggested from the previous literature on rhinovirus that relates to lung epithelial cells, it is likely that any induction of asthma-like symptoms is due to the production of inflammatory molecules in these cells, and/or production of molecules in lung-infiltrating cells such as neutrophils that are recruited by chemokines made as a direct consequence of the infection. We now substantiate these ideas. There may not be a single cell type that makes LIGHT, 35 Along with LIGHT, we found that RV infection also induced IL1b gene expression and again at least in part this was a consequence of the neutrophilia that accompanied infection. IL-1b was also active in driving airway remodeling, although similar to LIGHT its targets and mechanisms of action in this regard are not clear. IL-1b has been suggested to control avb8-mediated activation of TGF-b in fibroblasts, 31 and thus, neutralization of IL-1b in mice infected with RV1B
could have led to reduced TGF-b activity, although its likely range of activities linked to remodeling may be numerous. Correlating with the former, we did find that TGF-b was also required for features of the remodeling response induced by RV infection, and like blocking IL-1b or LIGHT, this was accompanied by decreased neutrophilia.
Again, the latter is likely related to migration as TGF-b has previously been found to be capable of directly stimulating neutrophil adhesion and chemotaxis. 40, 41 However, although TGF-b is universally considered to be central to airway fibrosis by directly promoting ECM proteins from epithelial cells or fibroblasts, 42 we observed This is of interest to understand in future studies.
In summary, this study extends our present knowledge of how RV alone or in combination with an allergen might contribute to airway dysfunction and specifically to fibrosis and lung tissue remodeling. We identify three molecules that contribute to these processes, although it is likely that other factors will also be induced directly or indirectly by RV that additionally are active. Importantly, two of these molecules in LIGHT and IL-1b might be amenable to targeting that could minimize the effects of multiple RV infections in early life that could contribute to wheezing in nonasthmatics, as well as could reduce exacerbations of wheezing in asthmatics that have previously responded to allergen.
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